Influence of dose and pharmaceutical formulation of vitamin A on plasma levels of retinyl esters and retinol and metabolic generation of retinoic acid compounds and β-glucuronides in the cynomolgus monkey
- 31 October 1991
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 111 (1), 116-127
- https://doi.org/10.1016/0041-008x(91)90140-a
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Vitamin A supplementation increases levels of retinoic acid compounds in human plasma: possible implications for teratogenesisArchives of Toxicology, 1990
- Characterization of oxidized and glucuronidated metabolites of retinol in monkey plasma by thermospray liquid chromatography/mass spectrometryJournal of Mass Spectrometry, 1990
- Teratogenicity and placental transfer of All-trans-, 13-cis-, 4-oxo-all-trans-, and 4-oxo-13-cis-retinoic acid after administration of a low oral dose during organogenesis in miceToxicology and Applied Pharmacology, 1989
- Transplacental pharmacokinetics and teratogenicity of a single dose of retinol (vitamin A) during organogenesis in the mouseToxicology Letters, 1989
- Retinoic acid causes an anteroposterior transformation in the developing central nervous systemNature, 1989
- Structure-activity relationships of retinoids in developmental toxicologyToxicology and Applied Pharmacology, 1988
- Retinoic acid: Biochemistry and metabolismJournal of the American Academy of Dermatology, 1986
- Comparative teratogenic activities of two retinoids: Effects on palate and limb developmentTeratogenesis, Carcinogenesis, and Mutagenesis, 1984
- Toxicology, carcinogenicity, and teratogenicity of some orally administered retinoidsJournal of the American Academy of Dermatology, 1982
- Studies on the mode of action of excess of vitamin A. 9. Penetration of lipid monolayers by compounds in the vitamin A seriesBiochemical Journal, 1964